Imane El Dika

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Imane El Dika

Dec 16, 2024, 17:31 | Insight

GemCis-NabPaclitaxel vs. GemCis in first line of advanced biliary tract cancers

Erman Akkus shared on X: "GemCis-NabPaclitaxel vs. GemCis in 1L of advanced biliary tract cancers SWOG…

Nov 5, 2024, 11:14 | Insight

Eileen M. O’Reilly: Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma

Eileen M. O’Reilly, Oncologist at Memorial Sloan Kettering Cancer Centre, shared on X: “Adjuvant mFOLFIRINOX…

Oct 29, 2024, 09:39 | Insight

Anirban Maitra: Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC) led by Eileen M O’Reilly

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared…

Sep 24, 2024, 14:18 | Insight

Sergio Cifuentes: The Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer

Sergio Cifuentes, Cancer Research Project Manager at CENEIT Mexico, shared on X: "Check out my…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023